Biotechnology Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences May 26, 2022
Biotechnology Bio-Techne Celebrates 40,000 Unique RNAscope(TM) in situ Hybridization Probes, Targeting Any Gene, Any Tissue, Any Species. May 26, 2022
Biotechnology AXSM INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Axsome Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit May 26, 2022
Health LAWSUITS FILED AGAINST ABBV, AXSM and OKTA – Jakubowitz Law Pursues Shareholders Claims May 25, 2022
Biotechnology Galapagos to showcase commitment to rheumatoid arthritis care at the upcoming European League Against Rheumatism congress May 25, 2022
Search
Health
